{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:30:52Z","timestamp":1793327452307,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2025A1515011922"],"award-info":[{"award-number":["2025A1515011922"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2026A1515010456"],"award-info":[{"award-number":["2026A1515010456"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20240813105122030"],"award-info":[{"award-number":["JCYJ20240813105122030"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.biomaterials.2026.124628","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:42:17Z","timestamp":1789195337000},"page":"124628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Bright NIR-II fluorescence lipid membrane probes for labelling of biomimetic nanovesicles with image-guided targeted NIR-II mild photothermal-immunotherapy of orthotopic glioblastoma"],"prefix":"10.1016","volume":"338","author":[{"given":"Haiyan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yina","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genwen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0018-4949","authenticated-orcid":false,"given":"Zhijin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7981-0644","authenticated-orcid":false,"given":"Bing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biomaterials.2026.124628_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41571-019-0177-5","article-title":"Challenges to curing primary brain tumours","volume":"16","author":"Aldape","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic Horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124628_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41571-025-01020-2","article-title":"Targeting the glioblastoma resection margin with locoregional nanotechnologies","volume":"22","author":"Kisby","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s43018-025-01097-9","article-title":"Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity","volume":"7","author":"Moreno-Sanchez","year":"2026","journal-title":"Nat. Cancer"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124628_bib5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41571-025-01000-6","article-title":"Enhancing immunotherapy with tumour-responsive nanomaterials","volume":"22","author":"Linderman","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.biomaterials.2026.124628_bib6","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41590-025-02308-2","article-title":"Cancer vaccines as enablers of immunotherapy","volume":"26","author":"Khleif","year":"2025","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124628_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41571-024-00979-8","article-title":"Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions","volume":"22","author":"Wang","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.biomaterials.2026.124628_bib8","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41571-025-01035-9","article-title":"The next generation of immunotherapies for lung cancers","volume":"22","author":"Zhao","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124628_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s43018-025-00986-3","article-title":"The tumor microenvironment's role in the response to immune checkpoint blockade","volume":"6","author":"Aliazis","year":"2025","journal-title":"Nat. Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124628_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41577-025-01222-w","article-title":"Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape","volume":"26","author":"Fallarino","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124628_bib11","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/s41591-025-03607-9","article-title":"A new paradigm for immunotherapy in glioblastoma","volume":"31","author":"Ellenbogen","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2026.124628_bib12","article-title":"The promise of immunotherapy for central nervous system tumours","author":"Mahdi","year":"2025","journal-title":"Nat. Rev. Immunol., 26"},{"issue":"21","key":"10.1016\/j.biomaterials.2026.124628_bib13","doi-asserted-by":"crossref","first-page":"17902","DOI":"10.1021\/jacs.5c02731","article-title":"Engineering recombinant chimeric proteins that deliver therapies to the brain","volume":"147","author":"Zhang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-56930-7","article-title":"Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I\/II trial","volume":"16","author":"Weathers","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.biomaterials.2026.124628_bib15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41591-025-03512-1","article-title":"Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma","volume":"31","author":"Long","year":"2025","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib16","article-title":"Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via \u03b2-catenin\/PD-L1 signaling","volume":"16","author":"Guo","year":"2025","journal-title":"Nat. Commun."},{"issue":"41","key":"10.1016\/j.biomaterials.2026.124628_bib17","doi-asserted-by":"crossref","first-page":"37641","DOI":"10.1021\/jacs.5c12775","article-title":"Genetically engineered biomimetic nanoparticles for synergistic activation of glioma-associated macrophages against glioblastoma","volume":"147","author":"Luo","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"43","key":"10.1016\/j.biomaterials.2026.124628_bib18","doi-asserted-by":"crossref","first-page":"15468","DOI":"10.1021\/acs.nanolett.5c03032","article-title":"Synergistic dual-targeting bacterial extracellular vesicles delivering paclitaxel for precision glioblastoma therapy","volume":"25","author":"Sun","year":"2025","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-026-02976-y","article-title":"Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42365-5","article-title":"Adaptive design of mRNA-loaded extracellular vesicles for targeted immunotherapy of cancer","volume":"14","author":"Dong","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124628_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202306336","article-title":"Chimeric exosomes functionalized with STING activation for personalized glioblastoma immunotherapy","volume":"11","author":"Bao","year":"2023","journal-title":"Adv. Sci."},{"issue":"29","key":"10.1016\/j.biomaterials.2026.124628_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202504253","article-title":"Biomimetic hybrid PROTAC nanovesicles block multiple DNA repair pathways to overcome temozolomide resistance against orthotopic glioblastoma","volume":"37","author":"Xu","year":"2025","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib23","article-title":"Bioengineered hybrid dual-targeting nanoparticles reprogram the tumour microenvironment for deep glioblastoma photodynamic therapy","volume":"16","author":"Zhao","year":"2025","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124628_bib24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"8046","key":"10.1016\/j.biomaterials.2026.124628_bib25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41586-024-08171-9","article-title":"Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas","volume":"637","author":"Monje","year":"2024","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124628_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202306583","article-title":"The landscape of biomimetic nanovesicles in brain diseases","volume":"36","author":"You","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124628_bib27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jconrel.2022.12.027","article-title":"Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications","volume":"353","author":"Mondal","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124628_bib28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.addr.2021.03.020","article-title":"Approaches to surface engineering of extracellular vesicles","volume":"173","author":"Richter","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124628_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade2996","article-title":"Water-soluble extracellular vesicle probes based on conjugated oligoelectrolytes","volume":"9","author":"Zhou","year":"2023","journal-title":"Sci. Adv."},{"issue":"20","key":"10.1016\/j.biomaterials.2026.124628_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201989","article-title":"Conjugated oligoelectrolytes for long-term tumor tracking with incremental NIR-II emission","volume":"34","author":"Zhou","year":"2022","journal-title":"Adv. Mater."},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124628_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202318632","article-title":"NIR-II conjugated electrolytes as biomimetics of lipid bilayers for in vivo liposome tracking","volume":"63","author":"Meng","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"issue":"24","key":"10.1016\/j.biomaterials.2026.124628_bib32","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1039\/D2CS00014H","article-title":"Membrane-intercalating conjugated oligoelectrolytes","volume":"51","author":"Zhou","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"52","key":"10.1016\/j.biomaterials.2026.124628_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202208463","article-title":"Bandgap modulation and lipid intercalation generates ultrabright D\u2013A\u2013D-Based zwitterionic small-molecule nanoagent for precise NIR-II excitation phototheranostic applications","volume":"32","author":"Chen","year":"2022","journal-title":"Adv. Funct. Mater."},{"issue":"51","key":"10.1016\/j.biomaterials.2026.124628_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202406159","article-title":"Water-Soluble lipophilic near-infrared region II fluorophores for high-brightness lipid layer and lipid droplets imaging applications","volume":"20","author":"Xu","year":"2024","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124628_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20230097","article-title":"A high\u2010performance cell\u2010labeling NIR\u2010II dye for in vivo cell tracking","volume":"5","author":"Sun","year":"2024","journal-title":"View"},{"key":"10.1016\/j.biomaterials.2026.124628_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123770","article-title":"NIR-II fluorescence membrane probes for rapidly labelling hybrid of probiotic outer membrane vesicles and anti-PD-L1 scFv over-expressing cellular vesicles with targeted photothermal-immunotherapy of Colon cancer","volume":"327","author":"Yu","year":"2026","journal-title":"Biomaterials"},{"issue":"23","key":"10.1016\/j.biomaterials.2026.124628_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202500131","article-title":"Genetically engineered IL12\/CSF1R\u2010Macrophage membrane\u2010liposome hybrid nanovesicles for NIR\u2010II fluorescence imaging\u2010guided and membrane\u2010targeted mild photothermal\u2010immunotherapy of glioblastoma","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124628_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114258","article-title":"Engineering of exosome-liposome hybrid-based theranostic nanomedicines for NIR-II fluorescence imaging-guided and targeted NIR-II photothermal therapy of subcutaneous glioblastoma","volume":"245","author":"Liu","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib39","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1186\/s12951-024-03074-3","article-title":"Bright NIR-II emissive cyanine dye-loaded lipoprotein-mimicking nanoparticles for fluorescence imaging-guided and targeted NIR-II photothermal therapy of subcutaneous glioblastoma","volume":"22","author":"Huang","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s43586-024-00301-x","article-title":"Near-infrared II fluorescence imaging","volume":"4","author":"Schmidt","year":"2024","journal-title":"Nat. Rev. Methods Primers"},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124628_bib41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41566-024-01391-5","article-title":"In vivo NIR-II fluorescence imaging for biology and medicine","volume":"18","author":"Wang","year":"2024","journal-title":"Nat. Photonics"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s44222-022-00002-8","article-title":"Near-infrared luminescence high-contrast in vivo biomedical imaging","volume":"1","author":"Chen","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.biomaterials.2026.124628_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114697","article-title":"Second near-infrared window fluorescence nanoprobes for deep-tissue In Vivo multiplexed bioimaging","volume":"193","author":"Yang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124628_bib44","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41571-024-00892-0","article-title":"NIR-II light in clinical oncology: opportunities and challenges","volume":"21","author":"Zhang","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124628_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114536","article-title":"Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors","volume":"190","author":"Zhang","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.accounts.2c00586","article-title":"Fluorescent probes for lipid membranes: from the cell surface to organelles","volume":"56","author":"Klymchenko","year":"2022","journal-title":"Accounts Chem. Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124628_bib47","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1021\/jacs.0c10972","article-title":"Targeted solvatochromic fluorescent probes for imaging lipid order in organelles under oxidative and mechanical stress","volume":"143","author":"Danylchuk","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124628_bib48","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nmat2986","article-title":"Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents","volume":"10","author":"Lovell","year":"2011","journal-title":"Nat. Mater."},{"issue":"6","key":"10.1016\/j.biomaterials.2026.124628_bib49","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1002\/anie.202012594","article-title":"AIEgen-Lipid conjugate for rapid labeling of neutrophils and monitoring of their behavior","volume":"60","author":"Liu","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"15","key":"10.1016\/j.biomaterials.2026.124628_bib50","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1097\/QAD.0b013e3282eee548","article-title":"PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status","volume":"21","author":"Sauce","year":"2007","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2009.00767.x","article-title":"PD-1 signaling in primary T cells","volume":"229","author":"Riley","year":"2009","journal-title":"Immunol. Rev."},{"issue":"5271","key":"10.1016\/j.biomaterials.2026.124628_bib52","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.273.5271.104","article-title":"T cell activation determined by T cell receptor number and tunable thresholds","volume":"273","author":"Viola","year":"1996","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.biomaterials.2026.124628_bib53","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2319856121","article-title":"IL7 increases targeted lipid nanoparticle\u2013mediated mRNA expression in T cells In Vitro and In Vivo by enhancing T cell protein translation","volume":"121","author":"Tilsed","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"35","key":"10.1016\/j.biomaterials.2026.124628_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201802591","article-title":"Through scalp and skull NIR-II photothermal therapy of deep orthotopic brain tumors with precise photoacoustic imaging guidance","volume":"30","author":"Guo","year":"2018","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124628_bib55","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1039\/D0CS00664E","article-title":"Second near-infrared photothermal materials for combinational nanotheranostics","volume":"50","author":"Xu","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124628_bib56","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1039\/C7CS00522A","article-title":"Organic molecule-based photothermal agents: an expanding photothermal therapy universe","volume":"47","author":"Jung","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2026.124628_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s44222-026-00407-9","article-title":"In Vivo imaging of the immune system","author":"Jiang","year":"2026","journal-title":"Nat. Rev. Bioeng., 4"},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib58","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41420-025-02584-9","article-title":"Tumor metabolome remolded by low dose mitochondrial uncoupler elicites robust CD8+ T cell response","volume":"11","author":"Jiang","year":"2025","journal-title":"Cell Death Discov."},{"issue":"47","key":"10.1016\/j.biomaterials.2026.124628_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201903761","article-title":"Functionalized DNA enables programming exosomes\/vesicles for tumor imaging and therapy","volume":"15","author":"Fan","year":"2019","journal-title":"Small"},{"issue":"4","key":"10.1016\/j.biomaterials.2026.124628_bib60","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccell.2020.07.013","article-title":"Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors","volume":"38","author":"Leko","year":"2020","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.biomaterials.2026.124628_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf3700","article-title":"TCR-Engineered T cell therapy in solid tumors: state of the art and perspectives","volume":"9","author":"Baulu","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib62","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0812-8","article-title":"Targeting cancers through TCR-peptide\/MHC interactions","volume":"12","author":"He","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"41","key":"10.1016\/j.biomaterials.2026.124628_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202402692","article-title":"Homologous tumor targeting molybdenum-doped prussian blue for enhancing immunotherapy via PTT\/CDT and remodeled Tumor immune microenvironment","volume":"34","author":"Ma","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2026.124628_bib64","first-page":"312","article-title":"Reversing cold tumors to hot: an immunoadjuvant-functionalized metal-organic framework for multimodal imaging-guided synergistic photo-immunotherapy","volume":"6","author":"Fan","year":"2021","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2026.124628_bib65","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01307-2","article-title":"Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors","volume":"15","author":"Xu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2026.124628_bib66","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41416-022-02119-4","article-title":"Tumour-infiltrating lymphocytes: from prognosis to treatment selection","volume":"128","author":"Brummel","year":"2023","journal-title":"Br. J. Cancer"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226006526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:37:11Z","timestamp":1793324231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226006526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":66,"alternative-id":["S0142961226006526"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124628","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bright NIR-II fluorescence lipid membrane probes for labelling of biomimetic nanovesicles with image-guided targeted NIR-II mild photothermal-immunotherapy of orthotopic glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124628"}}